Cancer BiologybioRxivPreprint
Multi-model preclinical platform predicts clinical response of melanoma to immunotherapy
E. Perez-Guijarro, H. H. Yang, R. E. Araya…·G. Merlino
The paper develops a preclinical platform using syngeneic mouse models to predict melanoma patient response to immunotherapy and identifies a melanocytic plasticity signature linked to treatment outcomes.
DOI 10.1101/727826